1. A novel ESR2 frameshift mutation predisposes to medullary thyroid carcinoma and causes inappropriate RET expression. (July 2016) Authors: Read, M.; Smith, J.; Smith, V.; Morgan, N.; Wake, N.; Watkinson, J.; Wallis, Y.; Maher, E.; McCabe, C.; Woodward, E. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparative analysis of human and mouse expression data identifies distinct proto-oncogene PTTG- and PBF-associated genes in thyroid cancer. (July 2016) Authors: Read, M.; Fong, J.; Imruetaicharoenchoke, W.; Modasia, B.; Nieto, H.; Watkinson, J.; Boelaert, K.; Smith, V.; Turnell, A.; McCabe, C. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Implications of HLA-allele associations for the study of type IV drug hypersensitivity reactions. (4th March 2018) Authors: Sullivan, A.; Watkinson, J.; Waddington, J.; Park, B. K.; Naisbitt, D. J. Journal: Expert opinion on drug metabolism and toxicology Issue: Volume 14:Number 3(2018) Page Start: 261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗